BF
Brandon Folkes Rodman & Renshaw Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
MannKind Corp
MNKD
$1.64B
| $5.34 | $11 |
106%
upside
| Buy | 2 days ago |
|
|
VALN
2
Valneva
VALN
$752M
| $8.84 | $18 |
104%
upside
| Buy | 10 days ago |
|
3
Xeris Biopharma Holdings
XERS
$1.27B
| $7.89 | $10 |
27%
upside
| Buy | 23 days ago |
|
4
Collegium Pharmaceutical
COLL
$1.24B
| $39.23 | $44 |
12%
upside
| Buy | 24 days ago |
|
5
ANI Pharmaceuticals
ANIP
$2.08B
| $96 | $93 |
3%
downside
| Buy | 27 days ago |
|
6
CorMedix
CRMD
$956M
| $12.80 | $17 |
33%
upside
| Buy | 27 days ago |
|
7
Indivior
INDV
$3.09B
| $24.73 | $28 |
13%
upside
| Buy | 29 days ago |
|
8
Zevra Therapeutics
ZVRA
$501M
| $8.93 | $26 |
191%
upside
| Buy | 2 months ago |
|
9
Trevi Therapeutics
TRVI
$880M
| $7.23 | $21 |
190%
upside
| Buy | 3 months ago |
|
10
Omeros
OMER
$284M
| $4.18 | $9 |
115%
upside
| Buy | 9 months ago |
|
11
Emergent Biosolutions
EBS
$407M
| $7.63 | $16 |
110%
upside
| Buy | 11 months ago |
|
|
12
CorMedix
CRMD
$956M
| $12.80 | $13 |
2%
upside
| Buy | 1 year ago |
|
|
13
MannKind Corp
MNKD
$1.64B
| $5.34 | $8 |
50%
upside
| Buy | 1 year ago |
|
|
14
Trevi Therapeutics
TRVI
$880M
| $7.23 | $7 |
3%
downside
| Buy | 1 year ago |
|
15
Sanara MedTech
SMTI
$303M
| $34.04 | $59 |
73%
upside
| Overweight | 1 year ago |
|
16
Jazz Pharmaceuticals
JAZZ
$7.77B
| $128.02 | $180 |
41%
upside
| Overweight | 2 years ago |
|
17
Alkermes
ALKS
$4.77B
| $28.92 | $32 |
11%
upside
| Overweight | 3 years ago |
|
|
18
Collegium Pharmaceutical
COLL
$1.24B
| $39.23 | $22 |
44%
downside
| Neutral | 4 years ago |
|
|
19
Emergent Biosolutions
EBS
$407M
| $7.63 | $110 |
1,342%
upside
| Overweight | 5 years ago |
|
|
20
ANI Pharmaceuticals
ANIP
$2.08B
| $96 | $40 |
58%
downside
| Neutral | 5 years ago |
|